FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
About this item
Full title
Author / Creator
Publisher
Basingstoke: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Studies in animals show that fibroblast growth factor (FGF)-23 interferes with vascular reactivity induced by the nitric oxide (NO) system. To investigate the relationship between circulating FGF-23 levels and the response of forearm blood flow to ischemia (flow-mediated vasodilatation, FMD) and nitroglycerin, we tested 183 patients with stage 3–4...
Alternative Titles
Full title
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_755161745
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_755161745
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1038/ki.2010.194
